Aimed Alliance Quoted in Health Central Article
Aimed Alliance Counsel, Ashira Vantrees, was quoted in a recent Health Central article on the high health care costs experienced…
Browsing: Patients, Caregivers, and Advocates
New Know Your Rights Brochure for Individuals with Rare Endocrine Disorder
On February 27, Aimed Alliance released a new Know Your Rights brochure for patients with Rare Endocrine Disorders. An endocrine…
Let’s Talk: Questions & Conversations You Should Have with Your Health Care Provider
For many individuals it can feel overwhelming being diagnosed with a new rare or chronic condition. This can be especially true…
Aimed Alliance and 28 Other Advocacy Organizations Submit Amicus Brief In Copay Accumulator Lawsuit
Aimed Alliance, and twenty-eight other organizations asked the U.S. District Court for the District of Columbia to accept their amicus…
Healthy Equity in IBD Report Underscores Need For Community-Centered Solutions to Inequity
In 2022, Aimed Alliance recognized that health disparities exist in the inflammatory bowel disease (“IBD”) patient population. With rates of…
New Education Requirement for Prescribers of Controlled Substances
The Medication Access and Training Expansion (MATE) Act was incorporated into the Consolidated Appropriations Act of 2023. This bill requires…
Expansion of the 14-Day Injectable MOUD Limit to 45 Days
On December 29, 2022, President Biden signed the Consolidated Appropriations Act of 2023. Section 1264 amended Section 309A(a)(5) of the…
20 Organizations Urge Senate to Expand Access to Treatments for OUD
On November 2, Aimed Alliance hosted a legislative briefing on facilitating access to medications for opioid use disorders (“MOUD”). The…
Aimed Alliance Hosts Discussion on Step Therapy Reform in New York
On October 17, 2022, the New York Step Therapy Alliance hosted a roundtable meeting to discuss the current state of…
Aimed Alliance Urges Senators to Expand Access to Treatments for OUD
On November 2, 2022, Aimed Alliance hosted a legislative briefing on facilitating access to medications for opioid use disorders (“MOUD”).…